NEO NeoGenomics, Inc. - Common Stock
NeoGenomics, Inc. - Common Stock Hakkında Wikipedia'dan şirket genel bakışı
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Devamını oku
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.
Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.
## History
NeoGenomics first received state and national-level laboratory certifications in 2002. Three years later in 2005, the company developed a technical-only service model using FISH.
In 2013, the company launched its sequencing platform and was listed on the Nasdaq Stock Market as NEO. In 2014, NeoGenomics launched molecular tests including BTK and CALR mutation analysis.
In 2015, NeoGenomics acquired Clarient, Inc. and its subsidiary company, Clarient Diagnostic Services, Inc., a national cancer diagnostics laboratory with capabilities in immunohistochemistry for solid tumor cancers from GE Healthcare. Clarient is headquartered in Aliso Viejo, California; with an ancillary laboratory in Houston, Texas.
In November 2017, NeoGenomics established their first headquarters outside the United States in Rolle, Switzerland.
In September 2024, the District Court for the Middle District of North Carolina entered a permanent injunction against NeoGenomics’ accused RaDaR assay, which was preliminarily enjoined in December 2023.
Kaynak: Wikipedia (İngilizce), CC BY-SA 4.0 · Wikipedia'da Görüntüle ↗
NEO Hisse Senedi Özeti Fiyat, piyasa değeri, P/E, EPS, ROE, borç/öz sermaye, 52 haftalık aralık
NEO Hisse Senedi Fiyat Grafiği Teknik göstergeler ile günlük OHLCV — kaydır, yakınlaştır ve görünümünüzü özelleştirin
10 Yıllık Performans Gelir, net kar, marjlar ve EPS trendleri
Değerleme P/E, P/S, P/B, EV/EBITDA oranları — hisse senedi pahalı mı ucuz mu?
Kârlılık Brüt, faaliyet ve net kâr marjları; ROE, ROA, ROIC
Finansal Sağlık Borç, likidite, solventlik — bilanço gücü
Büyüme Gelir, EPS ve net gelir büyümesi: YOY, 3 Yıllık CAGR, 5 Yıllık CAGR
Sermaye Verimliliği Aktif devir hızı, stok devir hızı, alacak devir hızı
NEO Analist Uzlaşması Boğa ve ayı analist görüşleri, 12 aylık fiyat hedefi, yukarı yönlü potansiyel
- Güçlü Al 4 25,0%
- Al 7 43,8%
- Tut 5 31,2%
- Sat 0 0,0%
- Güçlü Sat 0 0,0%
12 Aylık Fiyat Hedefi
9 analist · 2026-08-14Kazanç Geçmişi EPS gerçekleşen vs tahmin, sürpriz %, kazanma oranı, bir sonraki kazanç tarihi
| Dönem | EPS Gerçek | EPS Tahmin | Sürpriz |
|---|---|---|---|
| 30 Haziran 2026 | $0.05 | $0.03 | 0.02% |
| 31 Mart 2026 | $0.01 | $0.01 | 0.00% |
| 31 Aralık 2025 | $0.06 | $0.04 | 0.02% |
| 30 Eylül 2025 | $0.03 | $0.02 | 0.01% |
| 30 Haziran 2025 | $0.03 | $0.02 | 0.01% |
| 31 Mart 2025 | $0.00 | $-0.01 | 0.01% |
Akran karşılaştırması (GICS alt sektörü) Anahtar metrikler sektördeki benzerlerine karşı
| Hisse Sembolü | Piyasa Değeri | P/E | Gelir YoY | Net Kar Marjı | ROE | Brüt Kar Marjı |
|---|---|---|---|---|---|---|
| NEO | $1.51B | -49.0 | 10.1% | -14.8% | -12.8% | 43.2% |
| AVAH | $1.70B | 7.7 | 20.2% | 9.2% | 246.6% | 33.3% |
| GRDN | — | — | 17.9% | 3.4% | 24.8% | 20.2% |
| ADUS | — | 20.6 | 23.2% | — | — | — |
| MD | $1.77B | 11.0 | -4.9% | 8.6% | 20.3% | — |
| WGS | — | — | — | — | — | — |
| ASTH | $1.21B | 53.9 | 56.4% | 0.71% | 3.0% | — |
| AGL | $7.14B | — | -2.1% | -6.6% | -146.1% | — |
| INNV | $500M | -16.8 | 11.8% | -3.5% | -12.0% | 18.0% |
| OMDA | $922M | -45.1 | 53.2% | -4.9% | -5.8% | 65.7% |
Tüm Temeller Tüm metrikler yıla göre — gelir tablosu, bilanço, nakit akışı
Gelir Tablosu 18
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $727M | $661M | $592M | $510M | $484M | $444M | $409M | $277M | $240M | $232M | $5M | $5M | |
| Cost of Revenue | $413M | $370M | $347M | $322M | $297M | $259M | $212M | $149M | $138M | $134M | $56M | $46M | |
| Gross Profit | $314M | $290M | $245M | $188M | $187M | $186M | $197M | $127M | $102M | $98M | $44M | $41M | |
| R&D Expense | $37M | $31M | $27M | $30M | $22M | $8M | $8M | $3M | $4M | $5M | $4M | $3M | |
| SG&A Expense | $273M | $260M | $243M | $243M | $221M | $144M | $128M | $85M | $70M | $64M | $34M | $24M | |
| Operating Expenses | $430M | $382M | $352M | $346M | $306M | $200M | $184M | $117M | $99M | $96M | $49M | $38M | |
| Operating Income | $-116M | $-92M | $-108M | $-158M | $-119M | $-14M | $13M | $10M | $3M | $2M | $-6M | $2M | |
| Interest Expense | · | · | $7M | $8M | $8M | $7M | $4M | $6M | $6M | · | $854.0K | $985.0K | |
| Interest Income | $9M | $18M | $17M | $6M | $3M | · | · | · | · | · | · | · | |
| Other Non-op | $296.0K | $-379.0K | $644.0K | $-213.0K | $-499.0K | $8M | $-5M | $14.0K | $-12.0K | $0 | $2M | $56.0K | |
| Pretax Income | $-110M | $-81M | $-97M | $-159M | $-15M | $-14M | $4M | $4M | $-3M | $-8M | $-4M | $1M | |
| Income Tax | $-2M | $-2M | $-9M | $-15M | $-7M | $-18M | $-4M | $1M | $-2M | $-2M | $-2M | $157.0K | |
| Net Income | $-108M | $-79M | $-88M | $-144M | $-8M | $4M | $8M | $3M | $-396.0K | $-6M | $-3M | $1M | |
| EPS (Basic) | · | · | · | · | · | · | · | · | · | · | $-0.04 | $0.02 | |
| EPS (Diluted) | · | · | · | · | · | · | · | · | · | · | $-0.04 | $0.02 | |
| Shares (Basic) | 128,101,000 | 126,658,000 | 125,502,000 | 124,217,000 | 119,962,000 | 108,579,000 | 100,470,000 | 85,618,000 | 79,426,000 | 77,542,000 | 60,526,000 | 53,483,000 | |
| Shares (Diluted) | 128,101,000 | 126,658,000 | 125,502,000 | 124,217,000 | 119,962,000 | 111,794,000 | 103,615,000 | 91,568,000 | 79,426,000 | 77,542,000 | 60,526,000 | 56,016,000 | |
| EBITDA | $-116M | $-92M | $-108M | $-158M | $-119M | $-14M | $13M | · | $2M | · | $-6M | · |
Bilanço 29
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $160M | $367M | $342M | $263M | $317M | $229M | $173M | $10M | $13M | $13M | $23M | $34M | |
| Receivables | $159M | $151M | $131M | $120M | $112M | $107M | $94M | $77M | $60M | $56M | $49M | $20M | |
| Inventory | $29M | $27M | $24M | $24M | $23M | $30M | $14M | $9M | $7M | $6M | $5M | $3M | |
| Prepaid Expense | $21M | $20M | $18M | $15M | $12M | $12M | $6M | $8M | $5M | $5M | $5M | $1M | |
| Other Current Assets | $7M | $12M | $8M | $8M | $8M | $5M | $3M | $561.0K | $1M | · | · | · | |
| Current Assets | $376M | $596M | $597M | $605M | $682M | $449M | $291M | $104M | $86M | $79M | $82M | $59M | |
| PP&E (Net) | $85M | $94M | $92M | $102M | $109M | $86M | $64M | $61M | $37M | $34M | $35M | $15M | |
| PP&E (Gross) | $294M | $284M | $250M | $234M | $219M | $179M | $133M | $111M | $77M | $61M | $61M | $35M | |
| Accum. Depreciation | $209M | $190M | $158M | $132M | $110M | $93M | $69M | $50M | $41M | $27M | $27M | $20M | |
| Goodwill | $524M | $523M | $523M | $523M | $527M | $211M | $199M | $198M | $147M | $147M | $147M | $3M | |
| Intangibles | $287M | $340M | $373M | $408M | $442M | $121M | $127M | $140M | $74M | $77M | $88M | $4M | |
| Other Non-current Assets | $9M | $6M | $5M | $5M | $7M | $5M | $3M | $3M | $891.0K | $174.0K | $129.0K | $141.0K | |
| Total Assets | $1.36B | $1.64B | $1.68B | $1.74B | $1.87B | $988M | $710M | $505M | $344M | $337M | $351M | $81M | |
| Accounts Payable | $23M | $22M | $20M | $21M | $18M | $25M | $20M | $18M | $10M | $17M | $12M | $6M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | $1M | |
| Current Liabilities | $88M | $301M | $96M | $90M | $87M | $73M | $64M | $61M | $36M | $38M | $40M | $15M | |
| Capital Leases | $63M | $61M | $68M | $69M | $72M | $42M | $24M | $5M | $5M | $5M | $5M | $5M | |
| Deferred Tax | $18M | $22M | $24M | $35M | $55M | $5M | $16M | $22M | $7M | · | $16M | $821.0K | |
| Other Non-current Liabilities | $12M | $12M | $13M | $13M | $14M | $4M | $4M | $3M | $283.0K | · | · | · | |
| Total Liabilities | $523M | $736M | $740M | $742M | $762M | $294M | $202M | $185M | $140M | $151M | $113M | $21M | |
| Long-term Debt | $342M | $541M | $538M | · | · | · | · | $102M | $97M | $98M | $55M | · | |
| Total Debt | $342M | $541M | · | · | · | $0 | · | · | $95M | · | $53M | · | |
| Common Stock | · | · | · | · | · | · | · | · | · | · | · | $60.0K | |
| Retained Earnings | $-434M | $-326M | $-247M | $-159M | $-15M | $-7M | $-11M | $-19M | $-58M | $-52M | $-22M | $-19M | |
| Treasury Stock | $0 | · | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $4.0K | $-206.0K | $-2M | $-4M | $-638.0K | $10.0K | $-2M | $-579.0K | $274.0K | · | · | · | |
| Stockholders' Equity | $837M | $902M | $942M | $998M | $1.11B | $694M | $507M | $320M | $172M | $162M | $209M | $60M | |
| Liabilities + Equity | $1.36B | $1.64B | $1.68B | $1.74B | $1.87B | $988M | $710M | $505M | $344M | $337M | $351M | $81M | |
| Shares Outstanding | 128,989,152 | 128,145,333 | 127,369,142 | 126,913,992 | 124,107,500 | 112,075,474 | 104,781,236 | 94,465,440 | 80,462,574 | 78,571,158 | 75,820,307 | 60,242,818 |
Nakit Akışı 15
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | $26M | $20M | $16M | $16M | $16M | $7M | $5M | |
| Stock-based Comp | $41M | $33M | $25M | $25M | $22M | $10M | $10M | $7M | $6M | $5M | $3M | $641.0K | |
| Deferred Tax | $-3M | $-3M | $-10M | $-15M | $-7M | $-18M | $-4M | $2M | $-2M | $-2M | $-2M | · | |
| Amort. of Intangibles | $32M | $33M | $35M | $34M | $23M | $10M | $10M | $6M | $7M | $7M | $412.0K | $295.0K | |
| Restructuring | $0 | $7M | $11M | $5M | $0 | $0 | · | · | · | · | · | · | |
| Operating Cash Flow | $5M | $7M | $-2M | $-66M | $-27M | $1M | $23M | $45M | $18M | $21M | $6M | $9M | |
| CapEx | $27M | $41M | $29M | $31M | $64M | $29M | $20M | $14M | $14M | $8M | $2M | $4M | |
| Investing Cash Flow | $-12M | $13M | $77M | $517.0K | $-632M | $-159M | $-20M | $-140M | $-14M | · | · | · | |
| Stock Issued | $962.0K | $5M | $5M | $13M | $15M | $20M | $11M | $9M | $3M | · | · | $34M | |
| Net Stock Activity | $962.0K | $5M | $5M | $13M | $15M | $20M | $11M | · | · | · | · | · | |
| Financing Cash Flow | $-200M | $5M | $5M | $12M | $725M | $236M | $159M | $92M | $-4M | · | · | · | |
| Net Change in Cash | · | · | · | · | · | $78M | $163M | $-3M | $296.0K | $-11M | $-10M | $29M | |
| Taxes Paid | $515.0K | $207.0K | $175.0K | $180.0K | $148.0K | $246.0K | $319.0K | $-31.0K | $284.0K | $290.0K | · | · | |
| Free Cash Flow | $-22M | $-34M | $-31M | $-97M | $-91M | $-28M | $3M | · | $4M | · | $4M | · | |
| Levered FCF | · | · | $-37M | $-98M | $-94M | $-26M | $-5M | · | · | · | $4M | · |
Kârlılık 8
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 43.2% | 43.9% | 41.3% | 36.9% | 38.6% | 41.8% | 48.1% | · | · | · | 875.1% | · | |
| Operating Margin | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% | -3.1% | 3.2% | · | · | · | -112.7% | · | |
| Net Margin | -14.8% | -11.9% | -14.9% | -28.3% | -1.7% | 0.94% | 2.0% | · | · | · | -50.7% | · | |
| Pretax Margin | -15.2% | -12.2% | -16.4% | -31.3% | -3.1% | -3.2% | 0.89% | · | · | · | -89.8% | · | |
| EBITDA Margin | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% | -3.1% | 3.2% | · | · | · | -112.7% | · | |
| ROA | -7.2% | -4.7% | -5.1% | -8.0% | -0.58% | 0.49% | 1.3% | · | -0.25% | · | -1.1% | · | |
| ROE | -12.8% | -8.7% | -9.3% | -14.3% | -0.74% | 0.61% | 1.6% | · | -0.50% | · | -1.9% | · | |
| ROIC | -9.6% | -6.2% | -10.4% | -14.3% | -5.9% | 0.60% | 5.6% | · | 0.21% | · | -1.2% | · |
Likidite ve Solventlik 5
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.3 | 2.0 | 6.2 | 6.7 | 7.8 | 6.1 | 4.5 | · | 2.4 | · | 2.5 | · | |
| Quick Ratio | 3.6 | 1.7 | 4.9 | 4.3 | 4.9 | 4.6 | 4.2 | · | 2.1 | · | 1.8 | · | |
| Debt / Equity | 0.4 | 0.6 | · | · | · | 0.0 | · | · | 0.5 | · | 0.3 | · | |
| LT Debt / Equity | 0.4 | 0.4 | · | · | · | · | · | · | 0.5 | · | 0.2 | · | |
| Interest Coverage | · | · | -15.6 | -104.7 | -23.4 | -2.0 | 3.5 | · | · | · | -6.6 | · |
Verimlilik 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | 0.3 | 0.3 | 0.3 | 0.5 | 0.7 | · | · | · | 0.0 | · | |
| Inventory Turnover | 14.9 | 14.6 | 14.3 | 13.5 | 11.2 | 11.8 | 18.4 | · | 20.1 | · | 14.5 | · | |
| Receivables Turnover | 4.7 | 4.7 | 4.7 | 4.4 | 4.4 | 4.4 | 4.8 | · | · | · | 0.1 | · |
Büyüme Oranları 3
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 10.1% | 11.7% | 16.1% | 5.2% | 9.0% | · | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.6% | 10.9% | 10.0% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 10.3% | · | · | · | · | · | · | · | · | · | · | · |
Değerleme (TTM) 14
| Metrik | Eğilim | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $727M | $661M | $592M | $510M | $484M | $444M | $409M | $277M | $240M | $232M | $5M | $5M | |
| Net Income TTM | $-108M | $-79M | $-88M | $-144M | $-8M | $4M | $8M | $3M | $-396.0K | $-6M | $-3M | $1M | |
| Market Cap | $1.51B | $2.10B | $2.05B | $1.15B | $3.82B | $5.64B | $2.76B | · | $713M | · | $597M | · | |
| Enterprise Value | $1.69B | $2.27B | · | · | · | $5.41B | · | · | $795M | · | $626M | · | |
| P/E | -49.0 | -68.7 | -67.4 | -38.5 | -142.2 | -224.3 | -121.9 | -52.5 | -36.9 | -35.7 | -196.8 | 208.5 | |
| P/S | 2.1 | 3.2 | 3.5 | 2.2 | 7.9 | 12.7 | 6.8 | · | 3.0 | · | 119.3 | · | |
| P/B | 1.8 | 2.3 | 2.2 | 1.1 | 3.5 | 8.1 | 5.4 | · | 4.1 | · | 2.8 | · | |
| P / Tangible Book | 58.7 | 52.6 | 45.0 | 17.1 | 27.5 | 15.6 | · | · | · | · | · | · | |
| P / Cash Flow | 288.1 | 298.9 | -1051.4 | -17.4 | -143.1 | 3864.0 | 118.2 | · | 39.5 | · | 93.3 | · | |
| P / FCF | -69.2 | -61.7 | -66.9 | -11.8 | -42.1 | -204.1 | 827.3 | · | 164.0 | · | 142.8 | · | |
| EV / EBITDA | -14.6 | -24.7 | · | · | · | -386.8 | · | · | 342.1 | · | -111.1 | · | |
| EV / FCF | -77.6 | -66.8 | · | · | · | -195.9 | · | · | 182.9 | · | 149.9 | · | |
| EV / Revenue | 2.3 | 3.4 | · | · | · | 12.2 | · | · | 3.3 | · | 125.2 | · | |
| Earnings Yield | -2.0% | -1.5% | -1.5% | -2.6% | -0.70% | -0.45% | -0.82% | -1.9% | -2.7% | -2.8% | -0.51% | 0.48% |
Gelir Tablosu 16
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $202M | $187M | $190M | $188M | $181M | $168M | $172M | $168M | $165M | $156M | $156M | $152M | $147M | $137M | $139M | $129M | |
| Cost of Revenue | $110M | $106M | $107M | $107M | $104M | $95M | $95M | $93M | $92M | $91M | $88M | $90M | $87M | $82M | $82M | $80M | |
| Gross Profit | $92M | $81M | $83M | $80M | $77M | $73M | $77M | $75M | $72M | $65M | $68M | $62M | $60M | $55M | $57M | $49M | |
| R&D Expense | $11M | $10M | $9M | $9M | $9M | $10M | $8M | $8M | $8M | $8M | $7M | $5M | $8M | $7M | $7M | $7M | |
| SG&A Expense | $64M | $66M | $64M | $70M | $72M | $68M | $64M | $67M | $63M | $66M | $60M | $61M | $60M | $62M | $55M | $64M | |
| Operating Expenses | $102M | $99M | $97M | $107M | $125M | $101M | $96M | $96M | $94M | $96M | $86M | $87M | $90M | $90M | $83M | $88M | |
| Operating Income | $-10M | $-18M | $-13M | $-27M | $-48M | $-28M | $-18M | $-21M | $-22M | $-31M | $-19M | $-24M | $-30M | $-35M | $-26M | $-40M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $2M | · | $-3M | $-3M | $2M | · | $139.0K | |
| Interest Income | $1M | $1M | $2M | $2M | $2M | $4M | $4M | $5M | $5M | $5M | $5M | $5M | $4M | $3M | · | · | |
| Other Non-op | $-17.0K | $-12.0K | $84.0K | $-335.0K | $482.0K | $65.0K | $-431.0K | $317.0K | $-2.0K | $-263.0K | $124.0K | $-96.0K | $730.0K | $-114.0K | $-1.0K | $25.0K | |
| Pretax Income | $2M | $-18M | $-12M | $-26M | $-46M | $-26M | $-16M | $-18M | $-19M | $-28M | $-15M | $-21M | $-27M | $-34M | $-26M | $-40M | |
| Income Tax | $-412.0K | $-472.0K | $-3M | $740.0K | $-724.0K | $266.0K | $-804.0K | $-150.0K | $-375.0K | $-620.0K | $-960.0K | $-3M | $-2M | $-3M | $-3M | $-3M | |
| Net Income | $2M | $-17M | $-10M | $-27M | $-45M | $-26M | $-15M | $-18M | $-19M | $-27M | $-14M | $-19M | $-24M | $-31M | $-23M | $-37M | |
| Shares (Basic) | 129,628,000 | 129,166,000 | -255,639,000 | 128,415,000 | 127,949,000 | 127,376,000 | -252,811,000 | 126,953,000 | 126,405,000 | 126,111,000 | -250,567,000 | 125,687,000 | 125,356,000 | 125,026,000 | -247,906,000 | 124,425,000 | |
| Shares (Diluted) | 130,831,000 | 129,166,000 | -255,639,000 | 128,415,000 | 127,949,000 | 127,376,000 | -252,811,000 | 126,953,000 | 126,405,000 | 126,111,000 | -250,567,000 | 125,687,000 | 125,356,000 | 125,026,000 | -247,906,000 | 124,425,000 | |
| EBITDA | $-10M | $-18M | · | $-27M | $-48M | $-28M | · | $-21M | $-22M | $-31M | · | $-24M | $-30M | $-35M | · | $-40M |
Bilanço 27
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $146M | $146M | $160M | $164M | $155M | $346M | $367M | $362M | $355M | $332M | · | $306M | $289M | $276M | · | $266M | |
| Receivables | $175M | $167M | $159M | $155M | $153M | $151M | $151M | $151M | $147M | $140M | · | $133M | $125M | $119M | · | $112M | |
| Inventory | $27M | $30M | $29M | $28M | $34M | $30M | $27M | $24M | $23M | $20M | · | $24M | $25M | $24M | · | $24M | |
| Prepaid Expense | $24M | $24M | $21M | $22M | $23M | $23M | $20M | $18M | $17M | $19M | · | $19M | $17M | $16M | · | $17M | |
| Other Current Assets | $10M | $7M | $7M | $11M | $10M | $12M | $12M | $8M | $9M | $9M | · | $9M | $8M | $8M | · | $8M | |
| Current Assets | $381M | $374M | $376M | $382M | $393M | $574M | $596M | $590M | $584M | $574M | · | $587M | $585M | $585M | · | $603M | |
| PP&E (Net) | $81M | $84M | $85M | $85M | $85M | $90M | $94M | $93M | $92M | $88M | · | $95M | $100M | $103M | · | $107M | |
| PP&E (Gross) | · | · | $294M | · | · | · | $284M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $223M | $216M | $209M | $209M | $201M | $199M | $190M | $181M | $176M | $168M | · | $155M | $147M | $139M | · | $125M | |
| Goodwill | $524M | $524M | $524M | $524M | $524M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | $523M | · | $523M | |
| Intangibles | $271M | $279M | $287M | $294M | $302M | $331M | $340M | $348M | $356M | $365M | · | $382M | $391M | $399M | · | $417M | |
| Other Non-current Assets | $9M | $10M | $9M | $8M | $7M | $6M | $6M | $6M | $4M | $4M | · | $5M | $5M | $5M | · | $7M | |
| Total Assets | $1.35B | $1.35B | $1.36B | $1.37B | $1.39B | $1.60B | $1.64B | $1.64B | $1.64B | $1.64B | · | $1.68B | $1.70B | $1.71B | · | $1.76B | |
| Accounts Payable | $21M | $26M | $23M | $23M | $27M | $16M | $22M | $17M | $17M | $18M | · | $17M | $18M | $23M | · | $14M | |
| Current Liabilities | $106M | $85M | $88M | $98M | $100M | $280M | $301M | $296M | $290M | $77M | · | $93M | $95M | $87M | · | $85M | |
| Capital Leases | $65M | $61M | $63M | $64M | $67M | $60M | $61M | $62M | $63M | $65M | · | $62M | $65M | $67M | · | $70M | |
| Deferred Tax | $17M | $17M | $18M | $21M | $20M | $21M | $22M | $23M | $23M | $23M | · | $25M | $29M | $32M | · | $38M | |
| Other Non-current Liabilities | $862.0K | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $12M | $13M | · | $13M | $13M | $13M | · | $14M | |
| Total Liabilities | $567M | $518M | $523M | $536M | $540M | $713M | $736M | $733M | $727M | $717M | · | $731M | $739M | $735M | · | $743M | |
| Long-term Debt | · | · | $342M | · | · | · | $541M | · | · | · | · | · | · | · | · | · | |
| Total Debt | $374M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Retained Earnings | $-449M | $-451M | $-434M | $-424M | $-397M | $-352M | $-326M | $-310M | $-293M | $-274M | · | $-233M | $-214M | $-190M | · | $-136M | |
| Treasury Stock | $25M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| AOCI | $4.0K | $4.0K | $4.0K | $71.0K | $29.0K | $-56.0K | $-206.0K | $-643.0K | $-1M | $-1M | · | $-2M | $-3M | $-3M | · | $-5M | |
| Stockholders' Equity | $786M | $829M | $837M | $838M | $854M | $888M | $902M | $908M | $916M | $923M | $942M | $947M | $956M | $974M | $998M | $1.01B | |
| Liabilities + Equity | $1.35B | $1.35B | $1.36B | $1.37B | $1.39B | $1.60B | $1.64B | $1.64B | $1.64B | $1.64B | · | $1.68B | $1.70B | $1.71B | · | $1.76B | |
| Shares Outstanding | 127,917,946 | 129,653,642 | 128,145,333 | 128,885,101 | 128,681,713 | 128,356,327 | 128,145,333 | 128,061,944 | 127,851,113 | 127,434,786 | 127,369,142 | 127,261,476 | 127,144,418 | 127,200,491 | 126,913,992 | 126,562,037 |
Nakit Akışı 13
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $8M | $10M | $8M | $10M | $12M | $11M | $8M | $0 | $9M | $8M | $7M | $0 | $6M | $5M | $5M | $4M | |
| Amort. of Intangibles | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $8M | $9M | $9M | $9M | $9M | $9M | $8M | |
| Restructuring | · | · | · | · | · | · | · | · | · | $2M | $1M | $2M | $3M | $5M | · | $0 | |
| Operating Cash Flow | $20M | $-8M | $1M | $9M | $20M | $-25M | $10M | $9M | $14M | $-26M | $18M | $-5M | $-2M | $-13M | $-4M | $-16M | |
| CapEx | $8M | $5M | $8M | $8M | $6M | $4M | $12M | $11M | $13M | $6M | $7M | $4M | $7M | $10M | $5M | $8M | |
| Investing Cash Flow | $-8M | $-5M | $-6M | $-277.0K | $-9M | $4M | $-5M | $-4M | $7M | $15M | $17M | $21M | $15M | $24M | $-1M | $-4M | |
| Stock Issued | $2M | $-338.0K | $431.0K | $765.0K | $-1M | $949.0K | $687.0K | $1M | $2M | $816.0K | $1M | $2M | $93.0K | $1M | $2M | $3M | |
| Net Stock Activity | · | $-338.0K | · | · | · | $949.0K | · | · | · | $816.0K | · | · | · | $1M | · | · | |
| Financing Cash Flow | $-12M | $-338.0K | $431.0K | $765.0K | $-202M | $949.0K | $687.0K | $1M | $2M | $816.0K | $1M | $2M | $64.0K | $1M | $2M | $3M | |
| Net Change in Cash | · | · | · | $9M | · | · | · | $7M | $23M | $-11M | · | $17M | $13M | $12M | · | $-18M | |
| Taxes Paid | $711.0K | $0 | $57.0K | $0 | $458.0K | $0 | $-112.0K | $143.0K | $87.0K | $89.0K | $0 | $0 | $175.0K | $0 | $25.0K | $26.0K | |
| Free Cash Flow | · | $-13M | · | · | · | $-30M | · | · | · | $-32M | · | · | · | $-23M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $-33M | · | · | · | · | · | · |
Kârlılık 8
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 45.6% | 43.3% | · | 42.8% | 42.6% | 43.6% | · | 44.6% | 44.1% | 41.9% | · | 41.0% | 40.8% | 40.0% | · | 38.0% | |
| Operating Margin | -4.9% | -9.8% | · | -14.4% | -26.3% | -16.6% | · | -12.6% | -13.3% | -19.6% | · | -15.9% | -20.3% | -25.6% | · | -30.7% | |
| Net Margin | 1.1% | -9.2% | · | -14.4% | -24.9% | -15.4% | · | -10.5% | -11.3% | -17.3% | · | -12.2% | -16.6% | -22.4% | · | -28.6% | |
| Pretax Margin | 0.91% | -9.4% | · | -14.1% | -25.3% | -15.3% | · | -10.6% | -11.6% | -17.7% | · | -14.1% | -18.1% | -24.6% | · | -30.8% | |
| EBITDA Margin | -4.9% | -9.8% | · | -14.4% | -26.3% | -16.6% | · | -12.6% | -13.3% | -19.6% | · | -15.9% | -20.3% | -25.6% | · | -30.7% | |
| ROA | 0.16% | -1.2% | · | -1.8% | -3.0% | -1.6% | · | -1.1% | -1.1% | -1.6% | · | -1.1% | -1.4% | -1.7% | · | -2.0% | |
| ROE | 0.27% | -2.0% | · | -3.1% | -5.1% | -2.9% | · | -1.9% | -2.0% | -2.9% | · | -1.9% | -2.4% | -3.0% | · | -3.4% | |
| ROIC | -1.0% | -2.1% | · | -3.3% | -5.5% | -3.2% | · | -2.3% | -2.4% | -3.2% | · | -2.2% | -2.9% | -3.3% | · | -3.6% |
Likidite ve Solventlik 5
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.6 | 4.4 | · | 3.9 | 3.9 | 2.1 | · | 2.0 | 2.0 | 7.5 | · | 6.3 | 6.2 | 6.8 | · | 7.1 | |
| Quick Ratio | 3.0 | 3.7 | · | 3.3 | 3.1 | 1.8 | · | 1.7 | 1.7 | 6.2 | · | 4.7 | 4.4 | 4.6 | · | 4.4 | |
| Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| LT Debt / Equity | 0.5 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -18.1 | · | 8.5 | 11.8 | · | · | -284.2 |
Verimlilik 3
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 3.6 | 3.6 | · | 4.1 | 3.6 | 3.8 | · | 3.8 | 3.8 | 4.1 | · | 3.7 | 3.7 | 3.4 | · | 3.5 | |
| Receivables Turnover | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 | 1.2 | 1.2 | · | 1.2 |
Değerleme (TTM) 13
| Metrik | Eğilim | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $757M | $724M | · | $705M | $682M | $657M | · | $641M | $620M | $592M | · | $565M | $538M | $508M | · | $492M | |
| Net Income TTM | $-87M | $-115M | · | $-116M | $-107M | $-89M | · | $-82M | $-89M | $-101M | · | $-110M | $-127M | $-152M | · | $-142M | |
| Market Cap | $1.87B | $962M | · | $995M | $941M | $1.22B | · | $1.89B | $1.77B | $2.00B | · | $1.57B | $2.04B | $2.21B | · | $1.09B | |
| Enterprise Value | $2.10B | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -60.8 | -30.9 | · | -32.2 | -30.5 | -39.5 | · | -61.5 | -57.8 | -65.5 | · | -51.2 | -67.0 | -72.5 | · | -35.9 | |
| P/S | 2.5 | 1.3 | · | 1.4 | 1.4 | 1.9 | · | 2.9 | 2.9 | 3.4 | · | 2.8 | 3.8 | 4.4 | · | 2.2 | |
| P/B | 2.4 | 1.2 | · | 1.2 | 1.1 | 1.4 | · | 2.1 | 1.9 | 2.2 | · | 1.7 | 2.1 | 2.3 | · | 1.1 | |
| P / Tangible Book | · | 37.2 | · | 50.3 | 33.5 | 35.6 | · | 50.5 | 48.3 | 55.8 | · | 36.6 | 47.8 | 42.4 | · | 14.9 | |
| P / Cash Flow | · | -118.2 | · | · | · | -48.1 | · | · | · | -77.3 | · | · | · | -174.5 | · | · | |
| P / FCF | · | -73.2 | · | · | · | -40.8 | · | · | · | -63.6 | · | · | · | -97.9 | · | · | |
| EV / EBITDA | -214.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| EV / Revenue | 2.8 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -1.6% | -3.2% | · | -3.1% | -3.3% | -2.5% | · | -1.6% | -1.7% | -1.5% | · | -1.9% | -1.5% | -1.4% | · | -2.8% |
Finansal Tablolar Gelir tablosu, bilanço, nakit akışı — yıllık, son 5 yıl
Gelir Tablosu
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Gelir | $727M | $661M | $592M | $510M | $484M |
| Brüt Kâr Marjı % | 43.2% | 43.9% | 41.3% | 36.9% | 38.6% |
| Faaliyet Kâr Marjı % | -15.9% | -13.9% | -18.2% | -30.9% | -24.5% |
| Net Gelir | $-108M | $-79M | $-88M | $-144M | $-8M |
Bilanço
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Borç / Öz Sermaye | 0.4 | 0.6 | — | — | — |
| Cari Oran | 4.3 | 2.0 | 6.2 | 6.7 | 7.8 |
| Cari Oran | 3.6 | 1.7 | 4.9 | 4.3 | 4.9 |
Nakit Akışı
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Serbest Nakit Akışı | $-22M | $-34M | $-31M | $-97M | $-91M |
Son Haberler Bu şirketten bahseden son manşetler
Metriklerim Kişisel izleme listeniz — Tam Temeller'den seçilen satırlar
Sizin için önemli olan metrikleri seçin — yukarıdaki Tam Temeller'deki herhangi bir satırın yanındaki ➕ düğmesine tıklayın.
Seçiminiz kaydedildi ve tüm hisse senetlerinde sizinle birlikte gelir.
Kurumsal Sahipler (13F) 301 dosya · $1.8B toplam · Tarih itibarıyla 30 Haziran 2026
Çeyreklik SEC Form 13F'lerinde bu hisse senedini tuttuklarını bildiren kurumlar. Yalnızca uzun pozisyonlar; tek bir başvuru sahibi, ayrı opsiyon bacakları için iki kez görünebilir. Büyük dengeleyici alım/satım bacakları genellikle piyasa yapımını veya korunmuş envanteri yansıtır, yönlü bir inancı değil.
| Yeni pozisyonlar | Çıkan pozisyonlar | Artırıldı | Azaldı | Net hisse senedi değişimi |
|---|---|---|---|---|
| 64 (+22 önceki Ç'ye göre) | 38 (+1 önceki Ç'ye göre) | 93 (+20 önceki Ç'ye göre) | 59 (-26 önceki Ç'ye göre) | +33.5M |
Q1 2026 ile karşılaştırıldı. SEC Form 13F başvuruları, çeyrek sonundan itibaren 45 gün içinde ve geç başvuranlar için kısa bir ek süre içinde tamamlanmalıdır — bu pencere içindeki çeyrekler, en son tam olarak raporlanan çifte tercih edilerek atlanır.
| Kurum | Değer | Hisse senetleri | % izlenen 13F'nin | Tür |
|---|---|---|---|---|
| First Light Asset Management, LLC | $179.158.241 | 12.279.523 | 9,76% | Hisse senetleri |
| VANGUARD GROUP INC | $150.953.759 | 12.836.204 | 8,22% | Hisse senetleri |
| FIRST TRUST ADVISORS LP | $147.552.477 | 10.113.261 | 8,04% | Hisse senetleri |
| Greenhouse Funds LLLP | $125.097.724 | 8.574.210 | 6,81% | Hisse senetleri |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $117.615.272 | 8.061.362 | 6,41% | Hisse senetleri |
| VANGUARD CAPITAL MANAGEMENT LLC | $84.082.418 | 5.763.017 | 4,58% | Hisse senetleri |
| STATE STREET CORP | $78.257.609 | 5.363.784 | 4,26% | Hisse senetleri |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $73.501.000 | 5.037.787 | 4,00% | Hisse senetleri |
| BRAIDWELL LP | $71.756.567 | 4.918.202 | 3,91% | Hisse senetleri |
| SCHRODER INVESTMENT MANAGEMENT GROUP | $61.886.083 | 4.342.883 | 3,37% | Hisse senetleri |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $50.558.727 | 3.465.300 | 2,75% | Alım opsiyonu |
| MILLENNIUM MANAGEMENT LLC | $44.930.518 | 3.079.542 | 2,45% | Hisse senetleri |
| TORONTO DOMINION BANK | $43.770.000 | 3.000.000 | 2,38% | Alım opsiyonu |
| GEODE CAPITAL MANAGEMENT, LLC | $42.933.596 | 2.942.009 | 2,34% | Hisse senetleri |
| Driehaus Capital Management LLC | $36.604.049 | 2.508.845 | 1,99% | Hisse senetleri |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $34.896.129 | 2.391.784 | 1,90% | Hisse senetleri |
| AMERICAN CAPITAL MANAGEMENT INC | $32.648.145 | 2.237.707 | 1,78% | Hisse senetleri |
| DIMENSIONAL FUND ADVISORS LP | $32.593.724 | 2.233.977 | 1,78% | Hisse senetleri |
| UBS Group AG | $32.581.659 | 2.233.150 | 1,77% | Alım opsiyonu |
| LOOMIS SAYLES & CO L P | $30.838.504 | 2.113.674 | 1,68% | Hisse senetleri |
| Aberdeen Group plc | $28.180.950 | 1.931.525 | 1,53% | Hisse senetleri |
| D. E. Shaw & Co., Inc. | $27.938.858 | 1.914.932 | 1,52% | Hisse senetleri |
| GLENMEDE TRUST CO NA | $20.985.657 | 1.438.359 | 1,14% | Hisse senetleri |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $17.689.018 | 1.212.407 | 0,96% | Hisse senetleri |
| SEGALL BRYANT & HAMILL, LLC | $15.850.518 | 1.086.396 | 0,86% | Hisse senetleri |
| VANGUARD FIDUCIARY TRUST CO | $12.685.640 | 869.475 | 0,69% | Hisse senetleri |
| AQR CAPITAL MANAGEMENT LLC | $11.918.848 | 816.919 | 0,65% | Hisse senetleri |
| SAMLYN CAPITAL, LLC | $11.869.359 | 813.527 | 0,65% | Hisse senetleri |
| Connor, Clark & Lunn Investment Management Ltd. | $11.707.337 | 802.422 | 0,64% | Hisse senetleri |
| Glenmede Investment Management, LP | $11.359.995 | 1.471.502 | 0,62% | Hisse senetleri |
| PRINCIPAL FINANCIAL GROUP INC | $9.141.555 | 626.563 | 0,50% | Hisse senetleri |
| HighMark Wealth Management LLC | $8.936.871 | 612.534 | 0,49% | Hisse senetleri |
| JUPITER ASSET MANAGEMENT LTD | $7.841.935 | 537.487 | 0,43% | Hisse senetleri |
| Public Sector Pension Investment Board | $6.526.545 | 447.330 | 0,36% | Hisse senetleri |
| Trexquant Investment LP | $6.358.074 | 435.783 | 0,35% | Hisse senetleri |
| GOLDMAN SACHS GROUP INC | $5.559.884 | 381.075 | 0,30% | Hisse senetleri |
| Bank of New York Mellon Corp | $5.554.938 | 380.736 | 0,30% | Hisse senetleri |
| Granite Investment Partners, LLC | $5.181.507 | 355.141 | 0,28% | Hisse senetleri |
| RHUMBLINE ADVISERS | $4.624.054 | 316.935 | 0,25% | Hisse senetleri |
| AMERIPRISE FINANCIAL INC | $4.623.822 | 316.917 | 0,25% | Hisse senetleri |
| Weiss Asset Management LP | $4.171.558 | 285.919 | 0,23% | Hisse senetleri |
| Swiss National Bank | $3.800.695 | 260.500 | 0,21% | Hisse senetleri |
| SUSQUEHANNA ADVISORS GROUP, INC. | $3.770.056 | 258.400 | 0,21% | Hisse senetleri |
| STATE OF WISCONSIN INVESTMENT BOARD | $3.680.109 | 252.235 | 0,20% | Hisse senetleri |
| Universal- Beteiligungs- und Servicegesellschaft mbH | $3.455.481 | 236.839 | 0,19% | Hisse senetleri |
| FMR LLC | $3.409.026 | 233.655 | 0,19% | Hisse senetleri |
| Squarepoint Ops LLC | $3.239.505 | 222.036 | 0,18% | Hisse senetleri |
| ExodusPoint Capital Management, LP | $3.128.811 | 214.449 | 0,17% | Hisse senetleri |
| Legal & General Group Plc | $2.907.700 | 199.294 | 0,16% | Hisse senetleri |
| PEAK6 LLC | $2.651.003 | 181.700 | 0,14% | Alım opsiyonu |
| FEDERATED HERMES, INC. | $2.510.064 | 172.040 | 0,14% | Hisse senetleri |
| BANK OF AMERICA CORP /DE/ | $2.221.357 | 152.252 | 0,12% | Hisse senetleri |
| WHITE PINE CAPITAL LLC | $2.167.184 | 148.539 | 0,12% | Hisse senetleri |
| PRUDENTIAL FINANCIAL INC | $2.017.870 | 138.305 | 0,11% | Hisse senetleri |
| AMERICAN CENTURY COMPANIES INC | $1.987.158 | 136.200 | 0,11% | Hisse senetleri |
| BlackRock, Inc. | $1.962.691 | 134.523 | 0,11% | Hisse senetleri |
| WELLS FARGO & COMPANY/MN | $1.943.067 | 133.178 | 0,11% | Hisse senetleri |
| STEELHEAD PARTNERS LLC | $1.885.028 | 129.200 | 0,10% | Hisse senetleri |
| BNP PARIBAS FINANCIAL MARKETS | $1.787.859 | 122.540 | 0,10% | Hisse senetleri |
| Greenhouse Funds LLLP | $1.689.522 | 115.800 | 0,09% | Alım opsiyonu |
| PERKINS CAPITAL MANAGEMENT INC | $1.605.483 | 110.040 | 0,09% | Hisse senetleri |
| GABELLI FUNDS LLC | $1.597.605 | 109.500 | 0,09% | Hisse senetleri |
| ARISTEIA CAPITAL, L.L.C. | $1.571.343 | 107.700 | 0,09% | Hisse senetleri |
| IEQ CAPITAL, LLC | $1.524.305 | 104.476 | 0,08% | Hisse senetleri |
| Verition Fund Management LLC | $1.477.019 | 101.235 | 0,08% | Hisse senetleri |
| GAMCO INVESTORS, INC. ET AL | $1.459.000 | 100.000 | 0,08% | Hisse senetleri |
| Fernwood Investment Management, LLC | $1.453.536 | 88.200 | 0,08% | Hisse senetleri |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $1.440.244 | 194.103 | 0,08% | Hisse senetleri |
| XTX Topco Ltd | $1.413.552 | 96.885 | 0,08% | Hisse senetleri |
| VANGUARD ASSET MANAGEMENT, Ltd | $1.403.354 | 96.186 | 0,08% | Hisse senetleri |
| CITADEL ADVISORS LLC | $1.324.772 | 90.800 | 0,07% | Alım opsiyonu |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $1.279.178 | 87.675 | 0,07% | Hisse senetleri |
| Curi Capital, LLC | $1.256.666 | 86.132 | 0,07% | Hisse senetleri |
| MFG WEALTH MANAGEMENT, INC. | $1.217.711 | 83.462 | 0,07% | Hisse senetleri |
| ALLIANCEBERNSTEIN L.P. | $1.189.723 | 160.340 | 0,06% | Hisse senetleri |
| MetLife Investment Management, LLC | $1.120.293 | 76.785 | 0,06% | Hisse senetleri |
| Mariner, LLC | $1.117.405 | 76.587 | 0,06% | Hisse senetleri |
| Zurcher Kantonalbank (Zurich Cantonalbank) | $1.039.421 | 71.242 | 0,06% | Hisse senetleri |
| TWO SIGMA ADVISERS, LP | $983.136 | 83.600 | 0,05% | Hisse senetleri |
| Russell Investments Group, Ltd. | $967.068 | 66.283 | 0,05% | Hisse senetleri |
| VOYA INVESTMENT MANAGEMENT LLC | $962.429 | 65.965 | 0,05% | Hisse senetleri |
| MORGAN STANLEY | $954.638 | 65.431 | 0,05% | Hisse senetleri |
| Quantinno Capital Management LP | $945.359 | 64.795 | 0,05% | Hisse senetleri |
| Illinois Municipal Retirement Fund | $932.520 | 63.915 | 0,05% | Hisse senetleri |
| WINTON GROUP Ltd | $924.700 | 63.379 | 0,05% | Hisse senetleri |
| Quantbot Technologies LP | $922.540 | 63.231 | 0,05% | Hisse senetleri |
| CHOREO, LLC | $889.115 | 60.940 | 0,05% | Hisse senetleri |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $884.373 | 60.615 | 0,05% | Hisse senetleri |
| MOODY NATIONAL BANK TRUST DIVISION | $860.445 | 58.975 | 0,05% | Hisse senetleri |
| Louisiana State Employees Retirement System | $833.089 | 57.100 | 0,05% | Hisse senetleri |
| SIMPLEX TRADING, LLC | $796.453 | 54.589 | 0,04% | Hisse senetleri |
| JANE STREET GROUP, LLC | $786.401 | 53.900 | 0,04% | Alım opsiyonu |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $786.109 | 53.880 | 0,04% | Hisse senetleri |
| Teton Advisors, LLC | $774.729 | 53.100 | 0,04% | Hisse senetleri |
| Invesco Ltd. | $766.515 | 52.537 | 0,04% | Hisse senetleri |
| COMMERCE BANK | $764.632 | 52.408 | 0,04% | Hisse senetleri |
| Vanguard Global Advisers, LLC | $741.070 | 50.793 | 0,04% | Hisse senetleri |
| BARD ASSOCIATES INC | $683.761 | 46.865 | 0,04% | Hisse senetleri |
| Alamea Verwaltungs GmbH | $683.702 | 46.861 | 0,04% | Hisse senetleri |
| NEW YORK STATE COMMON RETIREMENT FUND | $674.467 | 46.228 | 0,04% | Hisse senetleri |
Şirket yöneticileri 52 içeriden öğrenenler · 30 yöneticiler · 23 yönetim kurulu üyeleri
| İçeriden Öğrenen | Rol | Son işlem | Sahip olunan hisse senetleri | Alımlar 12ay | Satışlar 12ay | Net 12ay |
|---|---|---|---|---|---|---|
| Anthony P. Zook | Chief Executive Officer | 01 Haziran 2025 M | 20.166 | 0 | 0 | $0 |
| Christopher M Smith | Chief Executive Officer | 23 Şubat 2025 M | 641.585 | 0 | 0 | $0 |
| Mark Mallon | Chief Executive Officer | 01 Mart 2022 A | 368.051 | 0 | 0 | $0 |
| Jeffrey Scott Sherman | Chief Financial Officer | 11 Mayıs 2025 M | 168.332 | 0 | 0 | $0 |
| William Bonello | Chief Financial Officer | 28 Nisan 2022 M | 191.548 | 0 | 0 | $0 |
| Sharon Virag | Chief Financial Officer | 01 Mart 2019 A | 10.944 | 0 | 0 | $0 |
| Vishal Sikri | President Advanced Diagnostics | 23 Şubat 2024 A | 148.455 | 0 | 0 | $0 |
| David Sholehvar | President, Clinical Services | 01 Ağustos 2022 A | 43.216 | 0 | 0 | $0 |
| George Cardoza | President & COO, Lab Ops | 02 Mart 2022 F | 244.157 | 0 | 0 | $0 |
| Gina M Wallar | President, Pharma Services | 01 Mart 2022 A | 33.443 | 0 | 0 | $0 |
| Clive Morris | President of Inivata | 30 Aralık 2021 A | 41.280 | 0 | 0 | $0 |
| Robert J. Shovlin | President, Clinical Services | 25 Mayıs 2021 M | 150.101 | 0 | 0 | $0 |
| Warren Stone | Pres & Chief Operating Officer | 11 Mayıs 2025 M | 108.280 | 0 | 0 | $0 |
| Alicia C Olivo | EVP, GC & Business Development | 01 Eylül 2025 F | 47.940 | 0 | 0 | $0 |
| Melody Harris | Chf Ops Off, Pres, Informatics | 23 Şubat 2025 M | 109.755 | 0 | 0 | $0 |
| Shashikant Kulkarni | Chief Scientific Officer | 01 Nisan 2023 F | 82.673 | 0 | 0 | $0 |
| Cynthia J Dieter | Chief Accounting Officer | 02 Mart 2023 F | 29.765 | 0 | 0 | $0 |
| Douglas Matthew Brown | Chief Strategy Officer | 01 Nisan 2022 A | 158.684 | 0 | 0 | $0 |
| Halley E Gilbert | Chief Legal Officer | 01 Mart 2022 A | 147.396 | 0 | 0 | $0 |
| Kathryn B Mckenzie | Chief Sustainability/Risk Ofcr | 11 Ocak 2022 M | 49.361 | 0 | 0 | $0 |
| Jennifer Balliet | VP and Chief Culture Officer | 30 Aralık 2021 A | 48.615 | 0 | 0 | $0 |
| Lawrence Martin Weiss | Chief Medical Officer | 22 Nisan 2021 M | 130.847 | 0 | 0 | $0 |
| Denise E Pedulla | General Counsel | 02 Mart 2021 A | 60.643 | 0 | 0 | $0 |
| Steven G. Brodie | VP - Pharma Operations | 22 Ekim 2018 M | 45.953 | 0 | 0 | $0 |
| Steven A Ross | CIO | 10 Mayıs 2018 X | 4.500 | 0 | 0 | $0 |
| Maher Albitar | Chief Medical Officer | 25 Mayıs 2017 A | 60.692 | 0 | 0 | $0 |
| Mark Alan Machulcz | Vice President of Operations | 28 Ocak 2016 A | — | 0 | 0 | $0 |
| Robert H. Horel | Vice President GM PathLogic | 29 Aralık 2015 X | 51.218 | 0 | 0 | $0 |
| Robert P Gasparini | Chief Science Officer | 22 Mayıs 2014 X | 8.439 | 0 | 0 | $0 |
| Mark W Smits | Chief Commercial Officer | 18 Mayıs 2011 M | 0 | 0 | 0 | $0 |
| Carolyn S Starrett | Yönetim kurulu üyesi | 23 Haziran 2026 A | — | 0 | 0 | $0 |
| Lynn A. Tetrault | Yönetim kurulu üyesi | 15 Haziran 2026 S | 86.115 | 0 | 2 | $-118.824 |
| Marjorie C Green | Yönetim kurulu üyesi | 01 Haziran 2026 A | 22.964 | 0 | 0 | $0 |
| Neil Gunn | Yönetim kurulu üyesi | 01 Haziran 2026 A | 51.177 | 0 | 0 | $0 |
| Michael Aaron Kelly | Yönetim kurulu üyesi | 01 Haziran 2026 A | 67.086 | 0 | 0 | $0 |
| David Brian Perez | Yönetim kurulu üyesi | 01 Haziran 2026 A | 56.967 | 0 | 0 | $0 |
| John P. Kenny | Yönetim kurulu üyesi | 01 Haziran 2026 A | 5.893 | 0 | 0 | $0 |
| Stephen M Kanovsky | Yönetim kurulu üyesi | 01 Haziran 2026 A | 75.421 | 0 | 0 | $0 |
| Felicia Williams | Yönetim kurulu üyesi | 01 Haziran 2026 A | 30.237 | 0 | 0 | $0 |
| Elizabeth Floegel | Yönetim kurulu üyesi | 01 Haziran 2025 A | 23.590 | 0 | 0 | $0 |
| Alison L. Hannah | Yönetim kurulu üyesi | 01 Haziran 2025 M | 131.023 | 0 | 0 | $0 |
| Bruce K Crowther | Yönetim kurulu üyesi | 10 Ağustos 2023 A | 65.120 | 0 | 0 | $0 |
| Rachel A Stahler | Yönetim kurulu üyesi | 10 Haziran 2022 A | 21.335 | 0 | 0 | $0 |
| David Daly | Yönetim kurulu üyesi | 10 Haziran 2022 A | 17.179 | 0 | 0 | $0 |
| Kevin C Johnson | Yönetim kurulu üyesi | 22 Aralık 2021 M | 37.398 | 0 | 0 | $0 |
| Douglas M Van Oort | Yönetim kurulu üyesi | 01 Ağustos 2021 F | 2.468.797 | 0 | 0 | $0 |
| Steven C Jones | Yönetim kurulu üyesi | 07 Ocak 2021 M | 90.218 | 0 | 0 | $0 |
| Raymond R Hipp | Yönetim kurulu üyesi | 16 Kasım 2020 S | 66.800 | 0 | 0 | $0 |
| William J Robison | Yönetim kurulu üyesi | 25 Mayıs 2017 A | 183.348 | 0 | 0 | $0 |
| Michael T Dent | Yönetim kurulu üyesi | 04 Aralık 2014 S | 1.384.150 | 0 | 0 | $0 |
SEC Form 3/4/5 başvurularından yöneticiler; net = yalnızca açık piyasa Alış/Satış
Aktivistler ve %5+ sahipler 1 pozisyon
SEC Çizelge 13D dosyalayan yatırımcılar — ihraççı üzerinde nüfuz etme niyetiyle %5'in üzerinde faydalı sahiplik (aktivist hisseler, yönetim kurulu kampanyaları, M&A). Her satır, o başvuru sahibinin pozisyonunun bilinen en son durumunu gösterir.
| Başvuru sahibi | Dosyalandı | Hisse | Durum | Amaç | Başvuru |
|---|---|---|---|---|---|
| IRS IDENTIFICATION NO. NeoGenomics, Inc. | 12 Nisan 2007 | — | İlk başvuru | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
ETF sahipliği 62 ETF'ler tarafından tutuluyor
Ağırlık yalnızca doğrudan öz sermaye varlıklarını (N-PORT) yansıtır; kaldıraçlı veya türev tabanlı fonlar gösterilmeyen ek swap pozisyonlarına sahip olabilir.
| Fon | Ağırlık | Birimler | Tarih itibarıyla | Kaynak |
|---|---|---|---|---|
| PTH · Invesco Exchange-Traded Fund Trust | 1,12% | 167.212 SH | 08 Ağustos 2026 | Günlük |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,09% | 113.008 SH | 08 Ağustos 2026 | Günlük |
| LFSC · RBB Fund, Inc. | 0,43% | 43.071 NS | 31 Mayıs 2026 | N-PORT |
| IHF · iShares Trust | 0,31% | 243.554 SH | 08 Ağustos 2026 | Günlük |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,14% | 154.408 NS | 30 Nisan 2026 | N-PORT |
| IJT · iShares Trust | 0,13% | 700.692 SH | 08 Ağustos 2026 | Günlük |
| XJR · iShares Trust | 0,13% | 15.435 SH | 08 Ağustos 2026 | Günlük |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,12% | 19.262 SH | 08 Ağustos 2026 | Günlük |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,12% | 211.878 SH | 08 Ağustos 2026 | Günlük |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,12% | 89.895 SH | 08 Ağustos 2026 | Günlük |
| IWN · iShares Trust | 0,12% | 1.117.630 SH | 08 Ağustos 2026 | Günlük |
| IJR · iShares Trust | 0,11% | 7.947.524 SH | 08 Ağustos 2026 | Günlük |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,11% | 104.297 SH | 08 Ağustos 2026 | Günlük |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,10% | 455.144 SH | 08 Ağustos 2026 | Günlük |
| NUSC · Nushares ETF Trust | 0,10% | 135.666 NS | 30 Nisan 2026 | N-PORT |
| IJS · iShares Trust | 0,09% | 489.210 SH | 08 Ağustos 2026 | Günlük |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,09% | 116.046 SH | 08 Ağustos 2026 | Günlük |
| ESML · iShares Trust | 0,09% | 158.897 SH | 08 Ağustos 2026 | Günlük |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,07% | 93.313 NS | 30 Nisan 2026 | N-PORT |
| GINN · Goldman Sachs ETF Trust | 0,07% | 13.856 NS | 31 Mayıs 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,07% | 85.056 SH | 08 Ağustos 2026 | Günlük |
| IWM · iShares Trust | 0,06% | 3.340.583 SH | 08 Ağustos 2026 | Günlük |
| ISCG · iShares Trust | 0,06% | 40.428 SH | 08 Ağustos 2026 | Günlük |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,06% | 49.165 NS | 30 Nisan 2026 | N-PORT |
| SAA · ProShares Trust | 0,06% | 1.546 NS | 31 Mayıs 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,06% | 757.699 SH | 08 Ağustos 2026 | Günlük |
| JPSE · J.P. Morgan Exchange-Traded Fund Tr… | 0,05% | 33.295 NS | 30 Nisan 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,05% | 1.728.845 SH | 08 Ağustos 2026 | Günlük |
| AVSC · AMERICAN CENTURY ETF TRUST | 0,04% | 106.278 NS | 31 Mayıs 2026 | N-PORT |
| RSSL · Global X Funds | 0,04% | 55.874 NS | 30 Nisan 2026 | N-PORT |
| ITWO · ProShares Trust | 0,03% | 6.071 NS | 31 Mayıs 2026 | N-PORT |
| ISCB · iShares Trust | 0,03% | 5.811 SH | 08 Ağustos 2026 | Günlük |
| VHT · VANGUARD WORLD FUND | 0,03% | 388.986 SH | 08 Ağustos 2026 | Günlük |
| SCHA · SCHWAB STRATEGIC TRUST | 0,03% | 628.556 NS | 31 Mayıs 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,03% | 425.333 NS | 30 Nisan 2026 | N-PORT |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,03% | 14.399 NS | 30 Nisan 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 1.492.431 SH | 08 Ağustos 2026 | Günlük |
| VB · VANGUARD INDEX FUNDS | 0,02% | 2.990.594 SH | 08 Ağustos 2026 | Günlük |
| UWM · ProShares Trust | 0,02% | 4.748 NS | 31 Mayıs 2026 | N-PORT |
| FHLC · FIDELITY COVINGTON TRUST | 0,02% | 60.531 NS | 30 Nisan 2026 | N-PORT |
| WSML · iShares Trust | 0,02% | 7.690 SH | 08 Ağustos 2026 | Günlük |
| SMLF · iShares Trust | 0,02% | 45.201 SH | 08 Ağustos 2026 | Günlük |
| URTY · ProShares Trust | 0,01% | 4.804 NS | 31 Mayıs 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,01% | 5.288 NS | 30 Nisan 2026 | N-PORT |
| IWO · iShares Trust | 0,01% | 113.167 SH | 08 Ağustos 2026 | Günlük |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,01% | 12.627 SH | 08 Ağustos 2026 | Günlük |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,01% | 5.219 NS | 31 Mayıs 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,01% | 339.840 NS | 30 Nisan 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,01% | 15.340 NS | 30 Nisan 2026 | N-PORT |
| HDG · ProShares Trust | 0,01% | 121 NS | 31 Mayıs 2026 | N-PORT |